Evidence map›Paper›PMID 32231493›Full record

ArticleBreast care (Basel, Switzerland)2020

Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy.

Francesca Pellini, Eleonora Granuzzo, Silvia Urbani, Sara Mirandola, Marina Caldana, Davide Lombardi, Elena Fiorio, Marta Mandarà, Giovanni Paolo Pollini

Registry-linked trialOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast care (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04837248 (Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer Surgery. A Clinical Trial.), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04837248 nacompletednot on this mapstarted 2021, after this paper: background citation

Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer Surgery. A Clinical Trial.

TypeinterventionalSponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalRan2021 to 2024Enrolled92ConditionsBreast CancerArmsActive Comparator: Group 1. Conventional treatment, Experimental: Group 2. Experimental treatment.
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Male Breast Cancer Patients: Lack of Evidence.Breast care (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesca PelliniComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Eleonora GranuzzoComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Silvia UrbaniComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Sara MirandolaComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Marina CaldanaComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Davide LombardiComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Elena FiorioComplex Operative Unit of Oncology, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.
Marta MandaràUnit of Oncology, San Bonifacio Hospital-ULSS 9, Verona, Italy.
Giovanni Paolo PolliniComplex Operative Unit of Breast Surgery, Breast Unit, Oncologic Surgery Department, AOUI, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMale breast cancer (MBC) is a rare disease with a rising incidence trend. The major risk factors related to MBC are a positive family history of breast cancer (BC) and

methodsIn this retrospective series, we enrolled 69 male patients presenting with male breast cancer (MBC) between 01/01/1992 and 31/12/2018, and 26 high-risk not-affected men presenting between 01/01/2016 and 31/12/2018. Participants' electronic clinical records were reviewed. Patients' data reported age at diagnosis, tumor characteristics, therapeutic management, and

resultsWe analyzed 69 MBC patients. Median age was 64 years. The majority of tumors diagnosed were of an early TNM stage. The most frequent histological subtype was invasive ductal carcinoma (76.7%). Hormone receptors were positive in >90% of MBC cases. Nearly all patients underwent modified radical mastectomy or total mastectomy. Adjuvant endocrine therapy was delivered in 59.4%. Among MBC-affected patients, we recorded a high percentage of a positive family history of BC. Mutational analysis for the DISCUSSION: We evaluated the distribution of clinicopathological characteristics in MBC subjects and assessed the frequency of mutations in the

Indexed as

BRCA1/2Male breast cancerProstate cancer

Identifiers

PMID32231493
PMCPMC7098299
OpenAlexW2972619352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.